CALL TOLL FREE:
FAX  TOLL  FREE:
1.866.930.3784
5:30 AM - 8:00 PM (M-F)
7:00 AM - 3:30 PM (S/S)

Bevespi (Glycopyrrolate/Formoterol Fumarate)

Type
Product
Manufacturer
Country
Dosage
Qty-Price (USD)
Type: drug type
Product: Bevespi
Manufacturer: AstraZeneca
Country: United Kingdom
Dosage: 7.2 mcg/5 mcg/120 dose
Qty-Price (USD):
Type: drug type
Product: Bevespi
Manufacturer: AstraZeneca
Country: United Kingdom
Dosage: 7.2 mcg/5 mcg/120 dose
Qty-Price (USD):

Generic Equivalent of Bevespi
Type
Product
Manufacturer
Country
Dosage
Qty-Price (USD)
Type: drug type
Product: Glycopyrrolate/Formoterol Fumarate
Manufacturer: Generic
Country: India
Dosage: 9 mcg/4.8 mcg/120 dose
Qty-Price (USD):

Bevespi Information

Bevespi and Glycopyrrolate/formoterol fumarate at CanadaPharmacyOnline.com

The manufacturer of brand-name Bevespi Aerosphere is AstraZeneca. This medication uses the "Aerosphere" delivery technology, designed to ensure the medicine remains consistently distributed within the inhaler and is delivered effectively to the small airways of the lungs.

Generic glycopyrrolate/formoterol fumarate is also available. The specific manufacturer of the medication dispensed may vary based on pharmacy inventory. Generic glycopyrrolate/formoterol fumarate is sourced from manufacturers that meet applicable regulatory standards.

Important Information about Generic Glycopyrrolate/formoterol fumarate

Generic glycopyrrolate/formoterol fumarate contains the same active ingredient as brand-name Bevespi. It must meet the same effectiveness and quality standards. This means it is designed to work like Bevespi. Studies have shown that generic glycopyrrolate/formeterol fumarate is bioequivalent to brand-name Bevespi, meaning it has similar absorption and achieves comparable blood concentrations. However, individual responses to medication can vary due to factors such as metabolism, genetics, and other health conditions.

For more information about generic drug approval and bioequivalence, please visit Access to Generic Drugs in Canada | Canada.ca.

Dosage:

Bevespi is available in the following strengths:
• Pressured metered-dose inhaler: 7.2 mcg of glycopyrrolate and 5 mcg formoterol fumarate per inhalation

The generic glycopyrrolate/formeterol fumarate is available in the strength of 9 mcg/4.8 mcg/120 dose inhaler.

The dosage is typically two inhalations twice daily (two puffs in the morning and two puffs in the evening). Do not use more than four inhalations in 24 hours.

Usage:

Bevespi is used for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is designed to be used every day, even when you are not feeling short of breath, to help keep your airways open over time. It is not approved for the treatment of asthma.

Mechanism of Action
Glycopyrrolate/formoterol fumarate is unique because it is a dual-acting medication that opens the airways in the lungs. Glycopyrrolate is a long-acting muscarinic antagonist (anticholinergic). It works by blocking the tightening signals sent by the nervous system to the muscles around the airways. Blocking these signals prevents the airways from constricting. Formoterol fumarate is a long-acting beta2-adrenergic agonist. It works by directly stimulating the "relaxation" receptors in the airway muscles. By both preventing bronchoconstriction and actively promoting relaxation, Bevespi provides a dual bronchodilatory effect that is often more effective than using either alone.

Use Bevespi as directed in the product monograph. Before using for the first time, or if not used for more than 7 days, shake well and release 4 test sprays into the air. Always shake the inhaler well before each use.

The information below summarizes some, but not all, potential side effects, risks, and interactions. Before starting Bevespi, it is essential to discuss all possible side effects, risks, and interactions with your doctor or pharmacist.

Side Effects:

The information below outlines potential side effects of Bevespi (glycopyrrolate/formoterol fumarate). It is not an exhaustive list, and individual reactions can vary.
Common side effects: These are common side effects of Bevespi; other side effects are possible. Contact your doctor promptly if any side effects are persistent, worsening, or concerning, or if you experience any other concerning symptoms.
• Cough
• Dizziness
• Headache
• Nausea
• Urinary Tract Infection (UTI)

Serious Side Effects: Seek immediate medical attention or call emergency services if you experience any of the following symptoms:
• Eye Issues: Eye pain, blurred vision, or seeing halos (signs of narrow-angle glaucoma).
• Heart Problems: Fast or irregular heartbeat, or increased blood pressure.
• Paradoxical Bronchospasm: Sudden, severe wheezing immediately after using the inhaler. If this happens, discontinue Bevespi and use a rescue inhaler immediately.
• Urinary Retention: Difficulty urinating or painful urination (especially in men with prostate issues).

Contraindications:

The following is not an exhaustive list of contraindications. Before starting Bevespi, it is crucial to discuss all your medical conditions, past and present, and all medications you are taking with your doctor or pharmacist.

Do not take Bevespi/glycopyrrolate/formeterol fumarate if:
• Allergies: You have a known hypersensitivity to glycopyrrolate or formoterol fumarate
• Asthma: This medicine can increase the risk of asthma-related death when not taken with a corticosteroid

Tell your doctor about all of your medical conditions, past and present, before starting Bevespi. This is crucial as certain conditions affect the drug's safety.
• Heart Conditions: Use with caution if you have a history of high blood pressure, arrhythmias, or heart disease.
• Narrow-Angle Glaucoma: The anticholinergic component of the medicine can worsen this condition.

Drug Interactions:

Before taking Bevespi, discuss all potential risks and interactions with your doctor or pharmacist. For complete and up-to-date information, please visit the manufacturer's website at https://www.bevespiaerosphere.com/.

Provide your doctor with a complete list of all your medications, including prescriptions, over-the-counter (OTC) drugs, vitamins, herbal supplements, recreational drugs, and any significant dietary changes, as these may interact with Bevespi. Bevespi may interact with other medicines, including but not limited to:
• Beta-Blockers: These can block the effects of formoterol fumarate and potentially cause severe bronchospasm.
• Diuretics: Using them together may lead to low potassium levels in the blood.
• Other Anticholinergics: Avoid using with similar medicines (e.g., Spiriva) as this can increase side effects.

Pregnancy and Breastfeeding:

There are no adequate studies on the use of this drug in pregnant women. Bevespi should be used during pregnancy only if the potential benefit justifies the risk. It is unknown if the components of Bevespi pass into human breast milk. Consult your doctor to weigh the risks.

Use in Children:

Bevespi is not approved for use in children. The safety and effectiveness of this medicine in children have not been established.

Frequently Asked Questions about Bevespi at Canada Pharmacy Online

Why is Bevespi more affordable in Canada than in the United States?

Prescription drug prices, including Bevespi, are generally lower in Canada than in the US due to a combination of factors, primarily government price regulations, differing market dynamics, and other economic considerations. In Canada, provincial and federal governments negotiate drug prices with pharmaceutical companies, which often results in lower prices than in the US, where market forces play a more significant role. For more information, see the FAQs on Prescription Drug Importation from the Kaiser Family Foundation (KFF): https://www.kff.org/health-costs/issue-brief/faqs-on-prescription-drug-importation/

How much is the shipping?

Our shipping fee is a flat rate of $10.00 per order. Our pharmacy is dedicated to offering you the lowest prices on high-quality products.

How do I place an order with your pharmacy?

Ordering from us is very simple. You can purchase online or call Customer Service at 1866.920.3784; for more information or to learn about the ordering process, visit our How to Order page.

Is there a limit on how many Bevespi I can order at once?

CanadaPharmacyOnline.com can dispense up to a three-month supply of Bevespi per prescription from your doctor.

Can I buy Bevespi from you over the counter?

No, Bevespi requires a valid prescription from your doctor. We do not sell this product without a valid prescription.

Do you ship to the United States?

Yes, we do. It usually takes between 7 and 18 business days to receive your order from our pharmacy.

Is there a generic for Bevespi?

Yes, the generic alternative, glycopyrrolate/formoterol fumarate, is available.

Blog Post:

Vaping, Is It A Safe Alternative Or Worse Than Smoking?

Latest News:

Mobile apps to help treat asthma and COPD patients (news published on April 6, 2026)

Similar Drugs in the category of Asthma Medication/ Respiratory Disorders:

   Flovent Inhaler    Advair    Symbicort Inhalation Aerosol    Spiriva Caps and Device    Albuterol

The information on this page is sourced from independent third parties contracted by CanadaPharmacyOnline. While we cannot guarantee its medical accuracy, we strongly recommend consulting a healthcare professional for personalized advice regarding medications or medical conditions.

Reviews From Real Customers
Drug Categories


Top Products

Prescriptions Dispensed from Canada are Dispensed by Candrug Pharmacy #18985. 202A 8322-130th Street, Surrey, British Columbia, Canada V3W 8J9, 604-543-8711. Pharmacy Manager: Carol Hou.
This pharmacy is duly licensed in the province of British Columbia, Canada by the College of Pharmacists of BC. If you have any questions or concerns you can contact the college at: 200-1765 West 8th Ave Vancouver, BC V6J 5C6 Canada.
All prices are in US dollars.
© Copyright 2006 - 2026 Canada Pharmacy Online. All Rights Reserved.